ScinoPharm Taiwan Ltd Free Cash Flow Generation Index
ScinoPharm Taiwan Ltd free cash flow generation index. ScinoPharm Taiwan Ltd (1789) has a Free Cash Flow Generation Index of 0.58x as of March 2026. Free cash flow of NT$116.13 Million represents 1% of operating cash flow (NT$199.47 Million). Check financial resilience of ScinoPharm Taiwan Ltd to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of ScinoPharm Taiwan Ltd (2007–2025)
Free cash flow generation index of ScinoPharm Taiwan Ltd from 2007 to 2025. Historical FCF Generation Index trend for ScinoPharm Taiwan Ltd across 19 annual periods. Explore 1789 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
ScinoPharm Taiwan Ltd Free Cash Flow Generation Index by Year (2007–2025)
ScinoPharm Taiwan Ltd free cash flow generation index by year from 2007 to 2025. Year-by-year Free Cash Flow Generation Index for ScinoPharm Taiwan Ltd. For the full cash flow conversion analysis, see ScinoPharm Taiwan Ltd cash conversion from operations.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.51x | NT$305.82 Million | NT$597.11 Million | NT$291.29 Million | ▼ -16.8% |
| 2024 | 0.62x | NT$462.18 Million | NT$750.91 Million | NT$288.73 Million | ▲ +365.5% |
| 2023 | -0.23x | NT$-53.59 Million | NT$231.13 Million | NT$284.71 Million | ▼ -134.3% |
| 2022 | 0.68x | NT$523.75 Million | NT$773.79 Million | NT$250.04 Million | ▲ +83.1% |
| 2021 | 0.37x | NT$188.50 Million | NT$509.82 Million | NT$321.32 Million | ▼ -54.2% |
| 2020 | 0.81x | NT$763.22 Million | NT$946.31 Million | NT$183.10 Million | ▼ -6.9% |
| 2019 | 0.87x | NT$683.25 Million | NT$788.95 Million | NT$105.70 Million | ▼ -3.4% |
| 2018 | 0.90x | NT$1.10 Billion | NT$1.23 Billion | NT$127.05 Million | ▲ +55.4% |
| 2017 | 0.58x | NT$560.79 Million | NT$971.71 Million | NT$410.93 Million | ▼ -20.4% |
| 2016 | 0.72x | NT$1.21 Billion | NT$1.67 Billion | NT$458.52 Million | ▲ +100.8% |
| 2015 | 0.36x | NT$376.95 Million | NT$1.04 Billion | NT$667.58 Million | ▲ +336.7% |
| 2014 | -0.15x | NT$-135.44 Million | NT$888.29 Million | NT$1.02 Billion | ▲ +53.0% |
| 2013 | -0.32x | NT$-304.77 Million | NT$939.47 Million | NT$1.24 Billion | ▼ -417.3% |
| 2012 | 0.10x | NT$100.36 Million | NT$981.55 Million | NT$881.19 Million | ▼ -72.7% |
| 2011 | 0.37x | NT$484.16 Million | NT$1.29 Billion | NT$810.14 Million | ▼ -49.5% |
| 2010 | 0.74x | NT$1.16 Billion | NT$1.56 Billion | NT$405.62 Million | ▼ -13.1% |
| 2009 | 0.85x | NT$1.11 Billion | NT$1.30 Billion | NT$191.28 Million | ▼ -5.0% |
| 2008 | 0.90x | NT$1.26 Billion | NT$1.41 Billion | NT$144.62 Million | ▲ +7.3% |
| 2007 | 0.84x | NT$421.75 Million | NT$504.50 Million | NT$82.74 Million | — |